 Robin Shandas
Concepts (383)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 34 | 2016 | 198 | 3.790 |
Why?
| | Pulmonary Artery | 28 | 2016 | 1086 | 3.320 |
Why?
| | Hypertension, Pulmonary | 25 | 2017 | 1910 | 2.370 |
Why?
| | Ultrasonography | 15 | 2017 | 759 | 2.270 |
Why?
| | Rheology | 9 | 2018 | 92 | 1.940 |
Why?
| | Pulmonary Circulation | 11 | 2017 | 429 | 1.920 |
Why?
| | Blood Flow Velocity | 25 | 2018 | 413 | 1.840 |
Why?
| | Microbubbles | 12 | 2013 | 49 | 1.810 |
Why?
| | Vascular Resistance | 9 | 2017 | 375 | 1.420 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2016 | 267 | 1.370 |
Why?
| | Hemorheology | 9 | 2005 | 22 | 1.050 |
Why?
| | Carotid Arteries | 5 | 2017 | 206 | 1.020 |
Why?
| | Hemodynamics | 10 | 2017 | 1113 | 0.970 |
Why?
| | Fontan Procedure | 8 | 2009 | 180 | 0.960 |
Why?
| | Contrast Media | 8 | 2017 | 467 | 0.950 |
Why?
| | Ultrasonography, Doppler | 4 | 2018 | 124 | 0.880 |
Why?
| | Algorithms | 9 | 2016 | 1704 | 0.850 |
Why?
| | Surgical Mesh | 2 | 2013 | 47 | 0.810 |
Why?
| | Blood Pressure | 14 | 2016 | 1786 | 0.810 |
Why?
| | Computer Simulation | 19 | 2018 | 978 | 0.790 |
Why?
| | Eosinophilia | 1 | 2024 | 218 | 0.730 |
Why?
| | Materials Testing | 6 | 2019 | 356 | 0.730 |
Why?
| | Polymers | 7 | 2018 | 490 | 0.720 |
Why?
| | Echocardiography, Doppler | 5 | 2006 | 108 | 0.700 |
Why?
| | Stress, Mechanical | 15 | 2018 | 485 | 0.660 |
Why?
| | Heart Ventricles | 5 | 2016 | 788 | 0.650 |
Why?
| | Arteries | 6 | 2013 | 269 | 0.640 |
Why?
| | Biomarkers | 2 | 2024 | 4149 | 0.630 |
Why?
| | Models, Biological | 7 | 2011 | 1783 | 0.610 |
Why?
| | Laparoscopy | 2 | 2013 | 466 | 0.600 |
Why?
| | Heart Defects, Congenital | 6 | 2007 | 842 | 0.570 |
Why?
| | Image Enhancement | 3 | 2009 | 190 | 0.570 |
Why?
| | Carotid Artery, Common | 1 | 2018 | 36 | 0.570 |
Why?
| | Models, Theoretical | 7 | 2013 | 578 | 0.550 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2017 | 752 | 0.540 |
Why?
| | Blood Pressure Determination | 3 | 2008 | 157 | 0.540 |
Why?
| | Transducers | 2 | 2009 | 27 | 0.520 |
Why?
| | Patient-Specific Modeling | 1 | 2016 | 41 | 0.520 |
Why?
| | Imaging, Three-Dimensional | 5 | 2013 | 580 | 0.490 |
Why?
| | Compliance | 4 | 2011 | 49 | 0.480 |
Why?
| | Ultrasonics | 3 | 2013 | 49 | 0.480 |
Why?
| | Elasticity | 10 | 2015 | 197 | 0.450 |
Why?
| | Reproducibility of Results | 12 | 2018 | 3284 | 0.450 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2022 | 545 | 0.440 |
Why?
| | Elastic Modulus | 3 | 2013 | 123 | 0.430 |
Why?
| | Hernia, Ventral | 1 | 2013 | 24 | 0.420 |
Why?
| | Polyesters | 1 | 2013 | 76 | 0.410 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2015 | 238 | 0.400 |
Why?
| | Ventricular Function, Right | 4 | 2017 | 285 | 0.400 |
Why?
| | Biocompatible Materials | 3 | 2013 | 425 | 0.390 |
Why?
| | Vasodilator Agents | 2 | 2011 | 331 | 0.380 |
Why?
| | Elastin | 2 | 2011 | 78 | 0.380 |
Why?
| | Equipment Failure Analysis | 5 | 2013 | 132 | 0.370 |
Why?
| | Heart-Assist Devices | 2 | 2009 | 552 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 3566 | 0.370 |
Why?
| | Cattle | 11 | 2017 | 984 | 0.360 |
Why?
| | Models, Anatomic | 3 | 2018 | 93 | 0.360 |
Why?
| | Heart Bypass, Right | 3 | 2006 | 17 | 0.350 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 40 | 0.350 |
Why?
| | Vena Cava, Inferior | 4 | 2006 | 71 | 0.340 |
Why?
| | Ventricular Function, Left | 3 | 2004 | 534 | 0.340 |
Why?
| | Vascular Stiffness | 6 | 2017 | 494 | 0.340 |
Why?
| | MicroRNAs | 1 | 2017 | 692 | 0.340 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 7 | 0.340 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2010 | 39 | 0.330 |
Why?
| | Shear Strength | 5 | 2017 | 67 | 0.320 |
Why?
| | Micro-Electrical-Mechanical Systems | 1 | 2009 | 5 | 0.320 |
Why?
| | Uncertainty | 1 | 2010 | 128 | 0.310 |
Why?
| | Numerical Analysis, Computer-Assisted | 4 | 2004 | 19 | 0.310 |
Why?
| | Animals | 32 | 2025 | 36940 | 0.300 |
Why?
| | Humans | 57 | 2024 | 137585 | 0.300 |
Why?
| | Miniaturization | 2 | 2009 | 22 | 0.300 |
Why?
| | Vena Cava, Superior | 3 | 2003 | 23 | 0.290 |
Why?
| | Child | 21 | 2018 | 21935 | 0.290 |
Why?
| | Aortic Valve | 2 | 2009 | 351 | 0.290 |
Why?
| | Sensitivity and Specificity | 9 | 2016 | 1946 | 0.280 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2004 | 32 | 0.280 |
Why?
| | Child, Preschool | 18 | 2017 | 11074 | 0.270 |
Why?
| | Tissue Scaffolds | 3 | 2019 | 211 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2017 | 261 | 0.270 |
Why?
| | Phantoms, Imaging | 4 | 2014 | 152 | 0.260 |
Why?
| | Heart Septal Defects | 1 | 2006 | 8 | 0.260 |
Why?
| | Linear Models | 4 | 2007 | 849 | 0.260 |
Why?
| | Gels | 2 | 2018 | 80 | 0.260 |
Why?
| | Pulsatile Flow | 6 | 2012 | 60 | 0.250 |
Why?
| | Vasomotor System | 1 | 2006 | 47 | 0.250 |
Why?
| | Lung | 4 | 2013 | 4060 | 0.250 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1092 | 0.240 |
Why?
| | Male | 26 | 2025 | 67762 | 0.240 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 193 | 0.240 |
Why?
| | Rats | 8 | 2025 | 5647 | 0.240 |
Why?
| | Tissue Engineering | 3 | 2019 | 423 | 0.230 |
Why?
| | Reference Values | 4 | 2018 | 816 | 0.230 |
Why?
| | Scattering, Radiation | 4 | 2006 | 101 | 0.230 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 526 | 0.230 |
Why?
| | Echocardiography | 3 | 2005 | 642 | 0.230 |
Why?
| | Female | 25 | 2025 | 73304 | 0.220 |
Why?
| | Cardiovascular System | 2 | 2006 | 137 | 0.220 |
Why?
| | Hypoxia | 1 | 2011 | 1112 | 0.220 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2005 | 89 | 0.220 |
Why?
| | Connective Tissue | 1 | 2004 | 36 | 0.220 |
Why?
| | Rats, Sprague-Dawley | 6 | 2019 | 2486 | 0.220 |
Why?
| | Breath Tests | 1 | 2024 | 87 | 0.210 |
Why?
| | Aorta | 2 | 2005 | 417 | 0.210 |
Why?
| | Physical Stimulation | 1 | 2004 | 65 | 0.210 |
Why?
| | Energy Transfer | 1 | 2004 | 46 | 0.210 |
Why?
| | Ventricular Function | 1 | 2004 | 61 | 0.210 |
Why?
| | Stroke Volume | 2 | 2017 | 612 | 0.210 |
Why?
| | Crystallization | 1 | 2004 | 143 | 0.210 |
Why?
| | Animals, Newborn | 5 | 2016 | 844 | 0.200 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 110 | 0.200 |
Why?
| | Gastritis | 1 | 2024 | 108 | 0.200 |
Why?
| | Nanotechnology | 1 | 2004 | 125 | 0.200 |
Why?
| | Enteritis | 1 | 2024 | 103 | 0.200 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 382 | 0.200 |
Why?
| | Temperature | 4 | 2025 | 679 | 0.200 |
Why?
| | Aortic Coarctation | 1 | 2003 | 83 | 0.190 |
Why?
| | Hydrogels | 3 | 2022 | 678 | 0.190 |
Why?
| | Biomechanical Phenomena | 4 | 2013 | 810 | 0.180 |
Why?
| | Coronary Angiography | 1 | 2004 | 317 | 0.180 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 179 | 0.180 |
Why?
| | Infant | 10 | 2015 | 9465 | 0.170 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 446 | 0.170 |
Why?
| | Cardiac Catheterization | 4 | 2015 | 530 | 0.170 |
Why?
| | Acrylamides | 2 | 2018 | 57 | 0.170 |
Why?
| | Adolescent | 14 | 2017 | 21513 | 0.170 |
Why?
| | Adipose Tissue | 1 | 2025 | 635 | 0.170 |
Why?
| | Delayed-Action Preparations | 2 | 2018 | 181 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2017 | 3556 | 0.160 |
Why?
| | Equipment Design | 4 | 2014 | 522 | 0.160 |
Why?
| | Regional Blood Flow | 6 | 2013 | 474 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 325 | 0.160 |
Why?
| | Hypertension | 1 | 2008 | 1295 | 0.150 |
Why?
| | Biomimetic Materials | 2 | 2017 | 72 | 0.150 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 1999 | 50 | 0.150 |
Why?
| | Models, Statistical | 3 | 2015 | 669 | 0.150 |
Why?
| | Particle Size | 4 | 2013 | 394 | 0.150 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 24 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 83 | 0.140 |
Why?
| | Gold | 1 | 2019 | 118 | 0.140 |
Why?
| | Sulfones | 1 | 2018 | 110 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2009 | 69 | 0.140 |
Why?
| | Heart Valve Diseases | 1 | 1999 | 151 | 0.140 |
Why?
| | Myocardial Infarction | 2 | 2022 | 1046 | 0.140 |
Why?
| | Bronchoscopy | 1 | 2018 | 223 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 47 | 0.130 |
Why?
| | Computer-Aided Design | 2 | 2009 | 43 | 0.130 |
Why?
| | Pressure | 4 | 2014 | 225 | 0.130 |
Why?
| | Finite Element Analysis | 3 | 2007 | 75 | 0.130 |
Why?
| | Cardiac Output | 1 | 2016 | 165 | 0.130 |
Why?
| | Laminin | 1 | 2016 | 72 | 0.120 |
Why?
| | Biomimetics | 1 | 2016 | 44 | 0.120 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.120 |
Why?
| | Endothelial Cells | 2 | 2012 | 785 | 0.120 |
Why?
| | Acoustics | 2 | 2006 | 42 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4295 | 0.120 |
Why?
| | Drug Carriers | 2 | 2013 | 128 | 0.120 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 129 | 0.120 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 2031 | 0.120 |
Why?
| | Arterial Pressure | 1 | 2015 | 126 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 64 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2013 | 198 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2017 | 2828 | 0.110 |
Why?
| | Bronchi | 1 | 2015 | 260 | 0.110 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 240 | 0.110 |
Why?
| | Pilot Projects | 2 | 2011 | 1710 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 996 | 0.110 |
Why?
| | Stearic Acids | 1 | 2013 | 15 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 1002 | 0.110 |
Why?
| | Lysine | 1 | 2016 | 294 | 0.110 |
Why?
| | Polyethyleneimine | 1 | 2013 | 18 | 0.110 |
Why?
| | Airway Extubation | 1 | 2014 | 57 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2017 | 4193 | 0.100 |
Why?
| | Phonophoresis | 1 | 2013 | 1 | 0.100 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 77 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 261 | 0.100 |
Why?
| | Feasibility Studies | 4 | 2015 | 956 | 0.100 |
Why?
| | Tensile Strength | 1 | 2013 | 97 | 0.100 |
Why?
| | Microspheres | 2 | 2006 | 137 | 0.100 |
Why?
| | Portal Vein | 1 | 2014 | 120 | 0.100 |
Why?
| | Industry | 1 | 2013 | 68 | 0.100 |
Why?
| | Herniorrhaphy | 1 | 2013 | 60 | 0.100 |
Why?
| | Silicon Dioxide | 1 | 2013 | 115 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 318 | 0.100 |
Why?
| | Collagen | 2 | 2012 | 452 | 0.100 |
Why?
| | Tetraspanin 28 | 1 | 2012 | 6 | 0.100 |
Why?
| | Time Factors | 4 | 2015 | 6828 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 257 | 0.090 |
Why?
| | Coronary Vessels | 2 | 2004 | 248 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2013 | 156 | 0.090 |
Why?
| | Paclitaxel | 1 | 2013 | 230 | 0.090 |
Why?
| | Sutures | 1 | 2012 | 58 | 0.090 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 570 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2013 | 191 | 0.090 |
Why?
| | Elastic Tissue | 1 | 2011 | 9 | 0.090 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 13 | 0.090 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 58 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 945 | 0.090 |
Why?
| | Models, Animal | 1 | 2013 | 384 | 0.090 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 229 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 332 | 0.090 |
Why?
| | Suture Techniques | 1 | 2012 | 122 | 0.090 |
Why?
| | Oscillometry | 2 | 2013 | 42 | 0.090 |
Why?
| | Swine | 1 | 2013 | 775 | 0.080 |
Why?
| | Arthroplasty | 1 | 2010 | 52 | 0.080 |
Why?
| | Intervertebral Disc Displacement | 1 | 2010 | 40 | 0.080 |
Why?
| | Equipment Failure | 1 | 2010 | 108 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 585 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 738 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2013 | 1178 | 0.080 |
Why?
| | Central Venous Pressure | 1 | 2009 | 14 | 0.080 |
Why?
| | Electric Capacitance | 1 | 2009 | 6 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 92 | 0.080 |
Why?
| | Coculture Techniques | 3 | 2019 | 239 | 0.080 |
Why?
| | Endothelial Growth Factors | 1 | 2009 | 64 | 0.080 |
Why?
| | Prostheses and Implants | 1 | 2010 | 143 | 0.080 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2000 | 37 | 0.080 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 153 | 0.080 |
Why?
| | Lipids | 1 | 2013 | 672 | 0.080 |
Why?
| | Mice | 8 | 2022 | 17787 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2009 | 139 | 0.070 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 443 | 0.070 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2025 | 204 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1147 | 0.070 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 804 | 0.070 |
Why?
| | Middle Aged | 4 | 2018 | 33479 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 181 | 0.070 |
Why?
| | Nanoparticles | 1 | 2013 | 481 | 0.070 |
Why?
| | Prosthesis Design | 2 | 2007 | 327 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2012 | 415 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 186 | 0.070 |
Why?
| | Logistic Models | 2 | 2015 | 2074 | 0.070 |
Why?
| | Electric Impedance | 1 | 2007 | 107 | 0.070 |
Why?
| | Tunica Media | 1 | 2007 | 38 | 0.070 |
Why?
| | Tunica Intima | 1 | 2007 | 84 | 0.070 |
Why?
| | Vasodilation | 2 | 2025 | 499 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2007 | 145 | 0.060 |
Why?
| | Probability | 1 | 2007 | 304 | 0.060 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 140 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1459 | 0.060 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 927 | 0.060 |
Why?
| | Blood Vessel Prosthesis | 1 | 2007 | 127 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1991 | 0.060 |
Why?
| | Aortic Valve Stenosis | 2 | 1999 | 229 | 0.060 |
Why?
| | Nanotubes | 1 | 2006 | 47 | 0.060 |
Why?
| | Venae Cavae | 1 | 2005 | 8 | 0.060 |
Why?
| | Protein Conformation | 1 | 2008 | 934 | 0.060 |
Why?
| | Hemolysis | 1 | 2006 | 206 | 0.060 |
Why?
| | Prospective Studies | 1 | 2017 | 7604 | 0.060 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 53 | 0.060 |
Why?
| | Radiography | 1 | 2007 | 822 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 553 | 0.050 |
Why?
| | Computing Methodologies | 1 | 2004 | 3 | 0.050 |
Why?
| | Manufactured Materials | 1 | 2004 | 8 | 0.050 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2004 | 10 | 0.050 |
Why?
| | ROC Curve | 2 | 2015 | 554 | 0.050 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 101 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2004 | 125 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1793 | 0.050 |
Why?
| | Rats, Wistar | 1 | 2025 | 455 | 0.050 |
Why?
| | Research Design | 1 | 2010 | 1139 | 0.050 |
Why?
| | Quality Control | 1 | 2004 | 172 | 0.050 |
Why?
| | Motion | 1 | 2004 | 99 | 0.050 |
Why?
| | Mitral Valve | 1 | 2004 | 88 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2691 | 0.050 |
Why?
| | Dogs | 1 | 2004 | 413 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2129 | 0.050 |
Why?
| | Heart | 1 | 2006 | 655 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2002 | 141 | 0.050 |
Why?
| | Heart Murmurs | 1 | 2001 | 14 | 0.050 |
Why?
| | Pediatrics | 2 | 2006 | 1101 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2253 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2009 | 2833 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2085 | 0.040 |
Why?
| | Binomial Distribution | 1 | 2000 | 7 | 0.040 |
Why?
| | Observer Variation | 1 | 2001 | 343 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1120 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 2 | 2012 | 111 | 0.040 |
Why?
| | Myosin Heavy Chains | 2 | 2012 | 192 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 93 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2015 | 15657 | 0.040 |
Why?
| | Risk Factors | 2 | 2015 | 10388 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 107 | 0.040 |
Why?
| | Albumins | 1 | 1999 | 114 | 0.040 |
Why?
| | Actins | 2 | 2012 | 416 | 0.040 |
Why?
| | Cell Line | 2 | 2014 | 2847 | 0.040 |
Why?
| | Formative Feedback | 1 | 2018 | 28 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 157 | 0.040 |
Why?
| | Mitral Valve Stenosis | 1 | 1998 | 18 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 948 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 4030 | 0.030 |
Why?
| | Gelatin | 1 | 2017 | 52 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3295 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 195 | 0.030 |
Why?
| | Sulfonic Acids | 1 | 2014 | 13 | 0.030 |
Why?
| | Demography | 1 | 2015 | 291 | 0.030 |
Why?
| | Phase Transition | 1 | 2014 | 24 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 314 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 29 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 86 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1864 | 0.030 |
Why?
| | Constriction, Pathologic | 3 | 2000 | 245 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2014 | 149 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 118 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2014 | 201 | 0.030 |
Why?
| | Airway Management | 1 | 2014 | 52 | 0.030 |
Why?
| | Young Adult | 3 | 2015 | 13209 | 0.030 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 8 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 20 | 0.030 |
Why?
| | Luciferases, Firefly | 1 | 2013 | 3 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 341 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2475 | 0.030 |
Why?
| | Patient Positioning | 1 | 2014 | 67 | 0.030 |
Why?
| | Porosity | 1 | 2013 | 102 | 0.030 |
Why?
| | Head | 1 | 2014 | 105 | 0.030 |
Why?
| | Trastuzumab | 1 | 2013 | 96 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 124 | 0.030 |
Why?
| | Sonication | 1 | 2013 | 13 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 194 | 0.030 |
Why?
| | Ramipril | 1 | 2012 | 6 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 374 | 0.020 |
Why?
| | Quantum Dots | 1 | 2013 | 37 | 0.020 |
Why?
| | Mass Screening | 1 | 2001 | 1287 | 0.020 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2012 | 52 | 0.020 |
Why?
| | Plasmids | 1 | 2013 | 363 | 0.020 |
Why?
| | Drug Compounding | 1 | 2013 | 101 | 0.020 |
Why?
| | Surface Properties | 1 | 2013 | 413 | 0.020 |
Why?
| | Solubility | 1 | 2013 | 245 | 0.020 |
Why?
| | Methylphenazonium Methosulfate | 1 | 2012 | 1 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Hypertrophy | 1 | 2012 | 133 | 0.020 |
Why?
| | Adult | 3 | 2010 | 37929 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 955 | 0.020 |
Why?
| | Treatment Outcome | 4 | 2013 | 10811 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 165 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2013 | 225 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 149 | 0.020 |
Why?
| | Liposomes | 1 | 2013 | 223 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 431 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1118 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1738 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1272 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2013 | 872 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 26 | 0.020 |
Why?
| | Prostaglandins F | 1 | 2009 | 17 | 0.020 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2009 | 25 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1226 | 0.020 |
Why?
| | E-Selectin | 1 | 2009 | 57 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2057 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 115 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 513 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.020 |
Why?
| | Software | 1 | 2013 | 665 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 641 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 182 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 206 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5757 | 0.020 |
Why?
| | Acrylates | 1 | 2007 | 47 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 378 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 437 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2011 | 528 | 0.020 |
Why?
| | Antigens, CD | 1 | 2009 | 521 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1316 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 843 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3412 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1759 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2009 | 915 | 0.010 |
Why?
| | Disease Progression | 1 | 2012 | 2757 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1502 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.010 |
Why?
| | Stents | 1 | 2007 | 527 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 1024 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 56 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2002 | 153 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1999 | 93 | 0.010 |
Why?
| | Veins | 1 | 1998 | 63 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5742 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2654 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2001 | 6079 | 0.000 |
Why?
| | Aged | 1 | 2005 | 23961 | 0.000 |
Why?
|
|
Shandas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|